Compare SJ & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SJ | CASI |
|---|---|---|
| Founded | 2011 | 1991 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.3M | 24.9M |
| IPO Year | N/A | 1996 |
| Metric | SJ | CASI |
|---|---|---|
| Price | $0.76 | $0.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 42.5K | 27.8K |
| Earning Date | 11-26-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $184,026,014.00 | $26,846,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.00 | ★ N/A |
| Revenue Growth | N/A | ★ 21.72 |
| 52 Week Low | $0.45 | $0.75 |
| 52 Week High | $1.06 | $3.29 |
| Indicator | SJ | CASI |
|---|---|---|
| Relative Strength Index (RSI) | 60.29 | 53.92 |
| Support Level | $0.65 | $0.82 |
| Resistance Level | $0.84 | $0.91 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 72.41 | 82.14 |
Scienjoy Holding Corp is a provider of mobile live streaming platforms in China and focuses on interactive show live streaming from broadcasters to users. It operates a mobile live streaming business by which it provides live streaming entertainment from professional broadcasters to end-users, allowing for the operation of live social video communities. Using its mobile applications, users can select broadcasters and enter real-time video rooms to interact with them. In addition to the real-time interaction, users can also view photos posted by broadcasters in their personal pages, leave comments, and engage in private chats with broadcasters when such broadcasters are not streaming. In addition, users can also play simple, fun games using virtual currencies within the video rooms.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.